Future multicenter prospective studies incorporating key clinical outcomes such as mortality and rehospitalization are warranted to validate these findings and explore the prognostic value of NT-proBNP across diverse populations and HF subtypes. This evidence concerns the gene NPPB and hydrops fetalis.